DrugPatentWatch Database Preview
B Braun Company Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the competitive landscape for B BRAUN, and when can generic versions of B BRAUN drugs launch?
B BRAUN has one hundred and twelve approved drugs.
There are two US patents protecting B BRAUN drugs.
There are twenty-four patent family members on B BRAUN drugs in twenty-five countries and one hundred and eighty-six supplementary protection certificates in fourteen countries.
Summary for B Braun
| International Patents: | 24 |
| US Patents: | 2 |
| Tradenames: | 221 |
| Ingredients: | 59 |
| NDAs: | 112 |
Drugs and US Patents for B Braun
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B Braun | POTASSIUM CHLORIDE 0.075% IN DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER | dextrose; potassium chloride; sodium chloride | INJECTABLE;INJECTION | 019630-038 | Feb 17, 1988 | RX | No | No | Start Trial | Start Trial | |||||
| B Braun | DEXTROSE 10% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER | dextrose; sodium chloride | INJECTABLE;INJECTION | 019631-011 | Feb 24, 1988 | RX | No | No | Start Trial | Start Trial | |||||
| B Braun | THEOPHYLLINE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER | theophylline | INJECTABLE;INJECTION | 019826-004 | Aug 14, 1992 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for B Braun
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| B Braun | HEPATAMINE 8% | amino acids | INJECTABLE;INJECTION | 018676-001 | Aug 3, 1982 | 3,950,529 | Start Trial |
| B Braun | UCEPHAN | sodium benzoate; sodium phenylacetate | SOLUTION;ORAL | 019530-001 | Dec 23, 1987 | 4,284,647 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for B Braun Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Russian Federation | 2015128024 | Start Trial |
| Poland | 1931304 | Start Trial |
| South Korea | 20150085131 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for B Braun Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2822954 | 18C1035 | France | Start Trial | PRODUCT NAME: BICTEGRAVIR OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE,EN PARTICULIER BICTEGRAVIR DE SODIUM; REGISTRATION NO/DATE: EU/1/18/1289 20180625 |
| 0484186 | CR 2011 00031 | Denmark | Start Trial | PRODUCT NAME: 4-AMINOPYRIDIN ELLER ET SALT DERAF, HERUNDER FAMPRIDIN; REG. NO/DATE: EU/1/11/699/001-002 20110720 |
| 1586316 | 122011100019 | Germany | Start Trial | PRODUCT NAME: BROMFENAC (2-AMINO-3-(4-BROMOBENZOYL)PHENYLESSIGSAEURE); REGISTRATION NO/DATE: EU/1/11/692/001 20110518 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
